Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Glesby, M. J. M.    Hoover, D. R.    Related Articles in PubMed    PubMed Citation    PubMed

PERSPECTIVE

Survivor Treatment Selection Bias in Observational Studies: Examples from the AIDS Literature

Marshall J. MD, Glesby and Donald R. Hoover, PhD

1 June 1996 | Volume 124 Issue 11 | Pages 999-1005

Unlike patients in a randomized, clinical trial, patients in an observational study choose if and when to begin treatment. Patients who live longer have more opportunities to select treatment; those who die earlier may be untreated by default. These facts are the essence of an often overlooked bias, termed "survivor treatment selection bias," which can erroneously lead to the conclusion that an ineffective treatment prolongs survival. Unfortunately, misanalysis of survivor treatment selection bias has been prevalent in the recent literature on the acquired immunodeficiency syndrome. Approaches to mitigating this bias involve complex statistical models. At a minimum, initiation of therapy should be treated as a time-dependent covariate in a proportional hazards model. Investigators and readers should be on the alert for survivor treatment selection bias and should be cautious when interpreting the results of observational treatment studies.

Author and Article Information

From Johns Hopkins University, Baltimore, Maryland.
Acknowledgments: The authors thank Wendy Tocci for preparing the figures and Dr. Ted Hoehn-Saric for his thoughtful review of the manuscript.
Grant Support: In part by contract IU0135042-01 from the National Institute of Allergy and Infectious Diseases.
Requests for Reprints: Donald R. Hoover, PhD, Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health, 624 North Broadway, Room 784, Baltimore, MD 21205.
Current Author Addresses: Dr. Glesby: Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Ross Research Building, Room 1159, 720 Rutland Avenue, Baltimore, MD 21205.

This article has been cited by other articles:

				S. Z. Shariff, M. S. Cuerden, A. K. Jain, and A. X. Garg The Secret of Immortal Time Bias in Epidemiologic Studies J. Am. Soc. Nephrol., May 1, 2008; 19(5): 841 - 843. [Full Text] [PDF]

				S. Suissa Immortal Time Bias in Pharmacoepidemiology Am. J. Epidemiol., February 15, 2008; 167(4): 492 - 499. [Abstract] [Full Text] [PDF]

				I. M. Tleyjeh, H. M.K. Ghomrawi, J. M. Steckelberg, T. L. Hoskin, Z. Mirzoyev, N. S. Anavekar, F. Enders, S. Moustafa, F. Mookadam, W. C. Huskins, et al. The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis Circulation, April 3, 2007; 115(13): 1721 - 1728. [Abstract] [Full Text] [PDF]

				M.-P. Sylvestre, E. Huszti, and J. A. Hanley Do OSCAR winners live longer than less successful peers? A reanalysis of the evidence. Ann Intern Med, September 5, 2006; 145(5): 361 - 363. [Abstract] [Full Text] [PDF]

				M. Briel, G. G. Schwartz, P. L. Thompson, J. A. de Lemos, M. A. Blazing, G.-A. van Es, M. Kayikcioglu, H.-R. Arntz, F. R. den Hartog, N. J. G. M. Veeger, et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA, May 3, 2006; 295(17): 2046 - 2056. [Abstract] [Full Text] [PDF]

				J. A. Ezekowitz, P. W. Armstrong, P. Kaul, F. A. McAlister, and C. Van Walraven Time-dependent analysis in CHF follow-up Can. Med. Assoc. J., August 2, 2005; 173(3): 239 - 239. [Full Text] [PDF]

				D. Vlahov, N. Galai, M. Safaeian, S. Galea, G. D. Kirk, G. M. Lucas, and T. R. Sterling Effectiveness of Highly Active Antiretroviral Therapy among Injection Drug Users with Late-Stage Human Immunodeficiency Virus Infection Am. J. Epidemiol., June 1, 2005; 161(11): 999 - 1012. [Abstract] [Full Text] [PDF]

				M Delgado-Rodriguez and J Llorca Bias J. Epidemiol. Community Health, August 1, 2004; 58(8): 635 - 641. [Abstract] [Full Text] [PDF]

				A. Laupacis and M. Mamdani Observational Studies of Treatment Effectiveness: Some Cautions Ann Intern Med, June 1, 2004; 140(11): 923 - 924. [Full Text] [PDF]

				J. Young, S. De Geest, R. Spirig, M. Flepp, M. Rickenbach, H. Furrer, E. Bernasconi, B. Hirschel, A. Telenti, P. Vernazza, et al. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study BMJ, January 3, 2004; 328(7430): 15. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]

				D.D. Sin and S.F.P. Man Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur. Respir. J., February 1, 2003; 21(2): 260 - 266. [Abstract] [Full Text] [PDF]

				S J Gange, Y Barron, R M Greenblatt, K Anastos, H Minkoff, M Young, A Kovacs, M Cohen, W A Meyer III, and A Munoz Effectiveness of highly active antiretroviral therapy among HIV-1 infected women J. Epidemiol. Community Health, February 1, 2002; 56(2): 153 - 159. [Abstract] [Full Text] [PDF]

				D. A. Redelmeier and S. M. Singh Survival in Academy Award-Winning Actors and Actresses Ann Intern Med, May 15, 2001; 134(10): 955 - 962. [Abstract] [Full Text] [PDF]

				S. K. Schwarcz, L. C. Hsu, E. Vittinghoff, and M. H. Katz Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996 Am. J. Epidemiol., July 15, 2000; 152(2): 178 - 185. [Abstract] [Full Text] [PDF]

				B. Swearingen, F. G. Barker II, L. Katznelson, B. M. K. Biller, S. Grinspoon, A. Klibanski, N. Moayeri, P. McL. Black, and N. T. Zervas Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3419 - 3426. [Abstract] [Full Text]

				R. S. Hogg, K. V. Heath, B. Yip, K. J. P. Craib, M. V. O'Shaughnessy, M. T. Schechter, and J. S. G. Montaner Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy JAMA, February 11, 1998; 279(6): 450 - 454. [Abstract] [Full Text] [PDF]

				S. Yerly, T. V. Perneger, B. Hirschel, O. Dubuis, L. Matter, R. Malinverni, H. Furrer, L. Perrin, and for the Swiss HIV Cohort Study A Critical Assessment of the Prognostic Value of HIV-1 RNA Levels and CD4+ Cell Counts in HIV-Infected Patients Arch Intern Med, February 9, 1998; 158(3): 247 - 252. [Abstract] [Full Text] [PDF]

				L. T. Cooper, G. J. Berry, R. Shabetai, and The Multicenter Giant Cell Myocarditis Study Group Idiopathic Giant-Cell Myocarditis -- Natural History and Treatment N. Engl. J. Med., June 26, 1997; 336(26): 1860 - 1866. [Abstract] [Full Text] [PDF]